Skip to Content

Kyprolis 60 mg powder for solution for infusion

Licence status
Authorised: 19/11/2015
Active substances
Carfilzomib
Dosage Form
Powder for solution for injection
Licence number
EU/1/15/1060/001
Licence holder
Amgen Europe B.V.,

Licence information

ATC code
L01XX Other antineoplastic agents, L01XX45 carfilzomib
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Conditions of Licence
Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).
Marketing availability
Unknown
Advertising conditions
Advertising to healthcare professionals only
Licence issued
19/11/2015